Oxbow Advisors, LLC Sanofi Transaction History

Oxbow Advisors, LLC

$747 Million
Q2 2024

A detailed history of Oxbow Advisors, LLC transactions in Sanofi stock. As of the latest transaction made, Oxbow Advisors, LLC holds 99,726 shares of SNY stock, worth $5.33 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

99,726

Previous 96,306 3.55%

Holding current value

$5.33 Million

Previous $4.68 Million 3.38%

% of portfolio

0.65%

Previous 0.67%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$45.39 - $50.36 $155,233 - $172,231	3,420 Added 3.55%	99,726 $4.84 Million
Q1 2024 May 06, 2024	BUY	$45.75 - $52.48 $92,049 - $105,589	2,012 Added 2.13%	96,306 $4.68 Million
Q4 2023 Feb 08, 2024	BUY	$43.13 - $54.79 $4.07 Million - $5.17 Million	94,294 New	94,294 $4.69 Million
Q3 2019 Oct 31, 2019	SELL	$40.34 - $46.64 $1.46 Million - $1.69 Million	-36,294 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$40.43 - $44.3 $50,537 - $55,375	1,250 Added 3.57%	36,294 $1.57 Million
Q1 2019 May 01, 2019	BUY	$40.83 - $45.43 $36,134 - $40,205	885 Added 2.59%	35,044 $1.55 Million
Q4 2018 Feb 12, 2019	SELL	$41.48 - $45.59 $1.69 Million - $1.86 Million	-40,825 Reduced 54.44%	34,159 $1.48 Million
Q3 2018 Nov 06, 2018	SELL	$40.0 - $44.84 $177,840 - $199,358	-4,446 Reduced 5.6%	74,984 $3.35 Million
Q2 2018 Aug 09, 2018	SELL	$37.63 - $41.22 $23,706 - $25,968	-630 Reduced 0.79%	79,430 $3.18 Million
Q1 2018 Apr 30, 2018	BUY	$38.98 - $45.76 $183,400 - $215,300	4,705 Added 6.24%	80,060 $3.21 Million
Q4 2017 Jan 30, 2018	BUY	$42.86 - $50.61 $126,437 - $149,299	2,950 Added 4.07%	75,355 $3.24 Million
Q3 2017 Oct 23, 2017	BUY	$47.04 - $50.34 $3.41 Million - $3.64 Million	72,405	72,405 $3.61 Million

Others Institutions Holding SNY

# of Institutions

807

Shares Held

253M

Call Options Held

2.6M

Put Options Held

1.64M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $134B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxbow Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oxbow Advisors, LLC with notifications on news.

Account

Oxbow Advisors, LLC Sanofi Transaction History